Affinity filamentous material for lyme disease biomarker capture from biological samples

Abstract

An embodiment of the invention relates to a method for diagnosing Lyme disease, comprising: isolating a diagnostic composition from a biological sample, wherein the biological sample is urine or another bodily fluid, the diagnostic composition comprising a biomarker attributable to Borrelia strains, bound or complexed to an affinity molecule that is bound or complexed to a filamentous material; and analyzing isolated diagnostic composition using a mass spectrometry, an immunoassay, a protein sequencing, or other analytical methods to detect presence of Borrelia-derived biomarkers.

Dependencies are inferred from the claim text.